Recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653 Conditions Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more Locations Mayo Clinic — Scottsdale, Arizona, United States City of Hope Medical Center — Duarte, California, United States Winship Cancer Institute of Emory University — Atlanta, Georgia, United States View Trial Details
Completed Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides NCT04101331 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more Locations University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) — Birmingham, Alabama, United States City of Hope Comprehensive Cancer Center — Duarte, California, United States University of California Los Angeles (UCLA) Health — Los Angeles, California, United States Emory University Clinic/Winship Cancer Institute — Atlanta, Georgia, United States View all 69 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Mechlorethamine Induced Contact Dermatitis Avoidance Study NCT03380026 Conditions Cutaneous T-Cell Lymphoma, Cutaneous T-cell Lymphoma Stage I, Dermatitis, +21 more Locations Rochester Skin Lymphoma Medical Group, PLLC — Fairport, New York, United States View Trial Details
